KPV Research Foundation Studies published in journals including Gut, Inflammatory Bowel Diseases, and the Journal of Immunology have shown that KPV reduces inflammation in models of colitis, with research by Kannengiesser and colleagues demonstrating that oral nanoparticle delivery of KPV decreases inflammation in dextran sulfate sodium (DSS)-induced colitis models
It is a small molecule that works by inhibiting the activity of an enzyme called nicotinamide N-methyltransferase (NNMT)
By replenishing vital nutrients, our therapy helps you bounce back quicker and reduces the risk of future infections
The standard titration schedule starts at 2.5 mg per week for 4 weeks, then increases to 5 mg per week for another 4 weeks, with subsequent increases of 2.5 mg every 4 weeks up to a maximum of 15 mg per week (Mounjaro prescribing information, Eli Lilly)
Overall lab experiments show BPC 157 helps tissue recover, supports gut health, and leads to better tissue condition in studies
Always check the label or talk to a doctor for the best advice